TORONTO–(BUSINESS WIRE)–TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, today announced that it has teamed with Riviera & West One Logistics to ensure the highest quality for its line of products including Hygen-X hand and surface sanitizer products. Riviera is a leading provider of bottled products in North America and overseas from an FDA-licensed facility in Southern California. TruTrace’s launch with the company will mark the first implementation of its proprietary TruTrace Enterprise™ SaaS platform in sectors outside of the medical cannabis sector.

Because of the COVID-19 pandemic, there has been a dramatic rise in the need for quality hand and surface sanitizer products around the world. Unfortunately, this high demand has also created a lineage of substandard products, highlighted by the FDA’s recent warnings about deficient and even dangerous products in the market. As a result, Riviera, in association with West One Logistics Hygen-X, has made transparency and product validation a top priority.

“Our vision when we started TruTrace was to provide transparent data on the quality of products of all types,” said Robert Galarza, CEO of TruTrace. “In light of the COVID-19 pandemic, we have seen a market flooded with disinfectants that are sub-standard, which is unacceptable. We are thrilled to be a catalyst for change in supporting top quality manufacturers like Riviera in their effort to distinguish from other operators.”

About TruTrace Technologies

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory. The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation.

For more information, please visit www.trutrace.co.

Disclaimer for Forward-Looking Information

This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of TruTrace, such as statements that TruTrace’s launch with Riviera and West One Logistics will mark the first implementation of its proprietary TruTrace EnterpriseTM SaaS platform in sectors outside of the medical cannabis sector; and that TruTrace will be a catalyst for change in supporting top quality manufacturers like Riviera in their effort to distinguish from other operators. There are numerous risks and uncertainties that could cause actual results and TruTrace’s plans and objectives to differ materially from those expressed in the forward-looking information, including adverse market conditions and other factors beyond TruTrace’s control. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. TruTrace disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.